These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2561248)

  • 1. Studies on drug resistance in chronic lymphocytic leukemia.
    Silber R; Potmesil M; Bank BB
    Adv Enzyme Regul; 1989; 29():267-76. PubMed ID: 2561248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.
    Bramson J; McQuillan A; Aubin R; Alaoui-Jamali M; Batist G; Christodoulopoulos G; Panasci LC
    Mutat Res; 1995 May; 336(3):269-78. PubMed ID: 7739615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione S-transferase activity, sulfhydryl group and glutathione levels, and DNA cross-linking activity with chlorambucil in chronic lymphocytic leukemia.
    Johnston JB; Israels LG; Goldenberg GJ; Anhalt CD; Verburg L; Mowat MR; Begleiter A
    J Natl Cancer Inst; 1990 May; 82(9):776-9. PubMed ID: 2325147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorambucil in chronic lymphocytic leukemia: mechanism of action.
    Begleiter A; Mowat M; Israels LG; Johnston JB
    Leuk Lymphoma; 1996 Oct; 23(3-4):187-201. PubMed ID: 9031099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro cytotoxicity of 2-chlorodeoxyadenosine and chlorambucil in chronic lymphocytic leukemia.
    Begleiter A; Wang H; Verburg L; Lee K; Israels LG; Mowat MR; Johnston JB
    Leukemia; 1996 Dec; 10(12):1959-65. PubMed ID: 8946937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs.
    Silber R; Degar B; Costin D; Newcomb EW; Mani M; Rosenberg CR; Morse L; Drygas JC; Canellakis ZN; Potmesil M
    Blood; 1994 Nov; 84(10):3440-6. PubMed ID: 7949099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of resistance to chlorambucil in chronic lymphocytic leukemia.
    Begleiter A; Goldenberg GJ; Anhalt CD; Lee K; Mowat MR; Israels LG; Johnston JB
    Leuk Res; 1991; 15(11):1019-27. PubMed ID: 1961006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione depletion in chronic lymphocytic leukemia B lymphocytes.
    Silber R; Farber CM; Papadopoulos E; Nevrla D; Liebes L; Bruck M; Brown R; Canellakis ZN
    Blood; 1992 Oct; 80(8):2038-43. PubMed ID: 1356514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemia.
    Christodoulopoulos G; Malapetsa A; Schipper H; Golub E; Radding C; Panasci LC
    Clin Cancer Res; 1999 Aug; 5(8):2178-84. PubMed ID: 10473103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance mechanisms in chronic lymphocytic leukemia.
    Ribrag V; Massade L; Faussat AM; Dreyfus F; Bayle C; Gouyette A; Marie JP
    Leukemia; 1996 Dec; 10(12):1944-9. PubMed ID: 8946935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imatinib sensitizes CLL lymphocytes to chlorambucil.
    Aloyz R; Grzywacz K; Xu ZY; Loignon M; Alaoui-Jamali MA; Panasci L
    Leukemia; 2004 Mar; 18(3):409-14. PubMed ID: 14712290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alkylator resistance in human B lymphoid cell lines: (2). Increased levels of topoisomerase II expression and function in a melphalan-resistant B-CLL cell line.
    Pu QQ; Bezwoda WR
    Anticancer Res; 2000; 20(4):2569-78. PubMed ID: 10953328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-Dependent protein kinase activity correlates with clinical and in vitro sensitivity of chronic lymphocytic leukemia lymphocytes to nitrogen mustards.
    Muller C; Christodoulopoulos G; Salles B; Panasci L
    Blood; 1998 Oct; 92(7):2213-9. PubMed ID: 9746757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia.
    Johnston JB; Daeninck P; Verburg L; Lee K; Williams G; Israels LG; Mowat MR; Begleiter A
    Leuk Lymphoma; 1997 Aug; 26(5-6):435-49. PubMed ID: 9389352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferase.
    Lefevre D; Riou JF; Ahomadegbe JC; Zhou DY; Benard J; Riou G
    Biochem Pharmacol; 1991 Jun; 41(12):1967-79. PubMed ID: 1645555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced activity of topoisomerase II in an Adriamycin-resistant human stomach-adenocarcinoma cell line.
    Son YS; Suh JM; Ahn SH; Kim JC; Yi JY; Hur KC; Hong WS; Muller MT; Chung IK
    Cancer Chemother Pharmacol; 1998; 41(5):353-60. PubMed ID: 9523730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of chlorambucil cytotoxicity in B-cell chronic lymphocytic leukemia by inhibition of DNA-dependent protein kinase activity using wortmannin.
    Christodoulopoulos G; Muller C; Salles B; Kazmi R; Panasci L
    Cancer Res; 1998 May; 58(9):1789-92. PubMed ID: 9581813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chlorambucil and purine analogs.
    Morabito F; Filangeri M; Callea I; Sculli G; Callea V; Fracchiolla NS; Neri A; Brugiatelli M
    Haematologica; 1997; 82(1):16-20. PubMed ID: 9107076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of human leukemic and normal lymphocytes to drug-induced DNA cleavage and low levels of DNA topoisomerase II.
    Potmesil M; Hsiang YH; Liu LF; Bank B; Grossberg H; Kirschenbaum S; Forlenza TJ; Penziner A; Kanganis D
    Cancer Res; 1988 Jun; 48(12):3537-43. PubMed ID: 2836060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair.
    Panasci L; Paiement JP; Christodoulopoulos G; Belenkov A; Malapetsa A; Aloyz R
    Clin Cancer Res; 2001 Mar; 7(3):454-61. PubMed ID: 11297233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.